ThokozeniLipatoMD

Hospital Medicine/Hospitalist

Assistant Professor, Medicine, University of Minnesota Medical School

Dr. Lipato is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1250 E Marshall St
Dept of Internal Medicinegen Medprimary Care
Richmond, VA 23298
Phone+1 804-828-9357

Fax+1 804-828-7591

PubMed

Dose by design: How limits on nicotine flux and puff duration affect the abuse liability of electronic nicotine delivery systems.
Rose S Bono, Augustus M White, Rabia Imran, Gabrielle T Maldonado, Thokozeni Lipato
Drug and Alcohol Dependence. 2025-01-01
Assessment of human abuse potential of an unflavored, sucralose-sweetened electronic cigarette in combustible cigarette smokers.
Sarah F Maloney, Cosima Hoetger, Rose S Bono, Rebecca Lester Scholtes, Madison Combs
Experimental and Clinical Psychopharmacology. 2024-10-01
2 citations
Constraining electronic nicotine delivery systems (ENDS) nicotine dose by controlling nicotine flux at a limited puff duration.
Alison J Patev, Madison Combs, Nicoleta Gaitan, Nareg Karaoghlanian, Thokozeni Lipato
Experimental and Clinical Psychopharmacology. 2024-10-01

Abstracts/Posters

Severity Classification for Sickle Cell Disease: A RAND/UCLA Modified Delphi Panel
Thokozeni Lipato, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Case Management Featuring Community Health Workers Reduces Inpatient Health Care Utilization in Adults with Sickle Cell Disease
Thokozeni Lipato, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Using Lean Six Sigma to Develop a Patient Centered Medical Home for Adults with Sickle Cell Disease
Thokozeni Lipato, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Promising New Sickle Cell Therapy Trialed at Children's Hospital of Richmond at VCU and VCU Medical CenterDecember 18th, 2023
Development of a Severity Classification System for Sickle Cell DiseaseOctober 28th, 2020